Article List

WPRIM Management System> DCMS> Korean Journal of Psychopharmacology> 2006> 17> 2

Volume: 17 Issue: 2

1. Vaginal Bleeding Associated with Venlafaxine Add-On Therapy: A Case Report.	Page:238—240
2. Two Cases of Citalopram Induced Awake Bruxism.	Page:233—237
3. A Case of Ultra-rapid Cycling Bipolar Disorder Recovered by Lamotrigine Combination.	Page:229—232
4. Early Treatment Response of Bupropion SR in Smoking Cessation according to Genetic Polymorphism and Temperamental Characteristics.	Page:219—228
5. Association Study of the -36C>T Polymorphism in the Cholecystokinin Promoter Gene with the Diagnosis and the Response of Pharmacotherapy in Korean Patients with Panic Disorder.	Page:212—218
6. The Effectiveness of 6-month Treatment with Citalopram in Korean Panic Disorder Patients: A Prospective, Open-labeled, Multi-Center Trial.	Page:203—211
7. Difference of Val-158-Met Catechol-O-Methyltransferase Gene Polymorphism between Early- and Late-onset Obsessive-Compulsive Disorder in Korea.	Page:197—202
8. Do the Postmenopausal Women Differently Respond to Antidepressant Medication?: Comparison of the Effect of Mirtazapine Treatment between the Premenopausal and Postmenopausal Women with Depression.	Page:188—196
9. Differences of Glucose and Lipid Metabolism among the Type of Antipsychotic Drugs in Schizophrenia Patients with Long-Term Use of Antipsychotic Drugs.	Page:181—187
10. Concomitant Use of Anticholinergic Agents with Atypical Antipsychotics in Schizophrenic Patients: A Preliminary Report.	Page:174—180
11. The Feasibility Test of Korean Medication Algorithm for the Treatment with Schizophrenic Patients(IV): Influences of a History of Antipsychotic Treatment on Effectiveness and Algorithm Application.	Page:162—173
12. The Feasibility Test of Korean Medication Algorithm for the Treatment with Schizophrenic Patients(III): The Influence of Therapeutic Environment on Application of Korean Medication Algorithm Project for Schizophrenia.	Page:149—161
13. The Role of Metabotropic Glutamate Receptors in Psychomotor Stimulant Addiction.	Page:143—148
14. The Newer Assessment Tools for Functionings and the Personal and Social Performance Scale in Patients with Schizophrenia.	Page:128—142
15. Global Assessment of Functioning Scale and Social and Occupational Functioning Scale.	Page:122—127
16. Improvement of Socio-Occupational Function in Schizophrenia.	Page:117—121